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Abstract
Microbial communities can augment host immune responses and probiotic therapies are under development to prevent or
treat diseases of humans, crops, livestock, and wildlife including an emerging fungal disease of amphibians,
chytridiomycosis. However, little is known about the stability of host-associated microbiota, or how the microbiota is
structured by innate immune factors including antimicrobial peptides (AMPs) abundant in the skin secretions of many
amphibians. Thus, conservation medicine including therapies targeting the skin will benefit from investigations of
amphibian microbial ecology that provide a model for vertebrate host-symbiont interactions on mucosal surfaces. Here, we
tested whether the cutaneous microbiota of Panamanian rocket frogs, Colostethus panamansis, was resistant to colonization
or altered by treatment. Under semi-natural outdoor mesocosm conditions in Panama, we exposed frogs to one of three
treatments including: (1) probiotic - the potentially beneficial bacterium Lysinibacillus fusiformis, (2) transplant – skin washes
from the chytridiomycosis-resistant glass frog Espadarana prosoblepon, and (3) control – sterile water. Microbial
assemblages were analyzed by a culture-independent T-RFLP analysis. We found that skin microbiota of C. panamansis was
resistant to colonization and did not differ among treatments, but shifted through time in the mesocosms. We describe
regulation of host AMPs that may function to maintain microbial community stability. Colonization resistance was
metabolically costly and microbe-treated frogs lost 7–12% of body mass. The discovery of strong colonization resistance of
skin microbiota suggests a well-regulated, rather than dynamic, host-symbiont relationship, and suggests that probiotic
therapies aiming to enhance host immunity may require an approach that circumvents host mechanisms maintaining
equilibrium in microbial communities.
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Introduction
Environmental changes leading to disruption of the host
microbiota, or dysbiosis, can lead to disease emergence [1,2,3].
Recent theory has focused on disturbance responses for microbial
communities and factors important for community stability [4,5].
Besides permanent change to an altered stable state, there are four
potential alternative responses to disturbance: (1) Resistance – the
microbial community does not change, (2) Resilience – the
microbial community is changed initially but then returns to its
original composition, (3) Functional redundancy – the microbial
community changes while maintaining the function of the original
composition, and (4) Restoration – the microbial community
recovers from a previously degraded state. Most microbial
communities in the environment, for example soil communities,
tend to be sensitive and not resistant to disturbance [5,6].
However, few studies have examined disturbances of host-
associated microbial communities, and active host regulation of
microbiota may produce greater stability than found in environ-
mental microbial communities. Indeed, a number of host processes
have been described directing the restoration or recovery of
microbiota following disturbance [7].
Intentional disturbances such as antibiotic treatments intended
to prevent or manage disease have the unintended effect of
disrupting beneficial microbiota [8]. Transfer of microbiota from
healthy to diseased hosts (e.g., fecal transplant) has proven more
effective than antibiotics against Clostridium difficile, and has
renewed interest in this type of therapy [9,10]. Mutualistic
microbial communities are linked with the health of organisms
across a broad taxonomic range [11,12]. In amphibian popula-
tions threatened by emerging disease, the microbial community
response to potential probiotic treatments is critical for effective
conservation management [13].
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A diverse microbiota has been found on amphibian skin [14–
20]. These cutaneous microbial communities extend host immune
function and are important in the prevention or outcome of
diseases such as chytridiomycosis, which is caused by the
pathogenic chytrid fungus Batrachochytrium dendrobatidis (Bd) in
amphibians [21,22]. The fungus is globally distributed on
hundreds of amphibian species [23]. While the impacts of
infection differ among species and depend on environmental
context [24,25], severe outbreaks can lead to extinctions or
collapse of regional amphibian faunas [26,27] and ecosystem
alterations [28]. In Panama, populations of the rocket frog,
Colostethus panamansis Dunn 1933, declined dramatically [27] and
Koch’s postulates were fulfilled for Bd as the causative agent of
chytridiomycosis [29]. While this species was extremely sensitive to
the disease, others, such as the glass frog Espadarana prosoblepon
Boettger 1892, were able to persist in smaller populations [27,30].
Growth of the fungus Bd is often inhibited by amphibian skin
microbiota [17–19,31,32], and probiotic application of antifungal
bacteria is a promising tool for disease mitigation [24,33]. While
sometimes effective, probiotic therapy has met with mixed results
[34–36]. Probiotic screening protocols and advances in application
method are under development [13]. Overcoming hurdles in
effective probiotic therapy will involve a better understanding of
the microbial ecology of amphibian skin, including the microbial
responses to disturbance, and the host responses that maintain a
functional microbiota.
Amphibian immune defenses are quite sophisticated and
include most components present in mammals [37]. One immune
component of particular relevance to skin infections includes
release of bioactive compounds into the mucosal layer. Antimi-
crobial peptides (AMPs) are synthesized in dermal granular glands
of many species [38–42]. AMPs are stored in the granular glands
and released to the skin surface when the animal is alarmed or
injured, and small amounts are constitutively expressed [43]. The
response is thought to be a non-specific and fast-acting innate
defense, although AMP responses can be closely linked with
adaptive immunity [44]. Amphibian skin peptides can directly
inhibit amphibian pathogens such as Bd, Basidiobolus ranarum or
ranaviruses in vitro [45–47]. Interactions between AMPs, micro-
biota, and environmental conditions may be important for
maintaining a functionally stable microbiota and is an ongoing
area of study [48–50].
Here, we examine AMP responses to three microbial treatments
of a threatened Central American amphibian. Frogs were treated
with a probiotic skin bacterium, treated with skin-wash transplants
from a disease-resistant species, or treated with sterile water as
controls. Resistance of the microbiota to colonization by
exogenous microbes would indicate that host mechanisms are
maintaining homeostasis. This knowledge will aid strategies to
enhance immune function and mitigate disease.
Materials and Methods
Study Species and Sites
In January 2011, we collected rocket frogs, C. panamansis
(n = 44), from a stream at the Sierra Llorona Lodge near Colo´n,
Panama. Glass frogs, E. prosoblepon (n = 17), were collected from
Omar Torrijos National Park, Cocle´ Province, Panama. Frogs
were transported to the El Valle Amphibian Conservation Centre
(EVACC) at El Nı´spero Zoological Park, El Valle, Panama.
Collecting permits were provided by the Autoridad Nacional del
Ambiente (ANAM), and all experimental procedures were
approved by the Smithsonian Tropical Research Institute (STRI)
Institutional Animal Care and Use Commission. After treatments,
frogs were monitored daily to record microhabitat use, behavior,
and animal welfare. After the experiment, all animals were
retained in captivity at EVACC and not released, according to
ANAM specifications.
Animal Care
All C. panamansis were housed individually in 60 L plastic
mesocosms situated on a shaded lawn at EVACC. The tubs were
filled with 2 to 3 L of filter-sterilized water and tilted to one side to
cover approximately one third of the surface, and a large rock was
provided as a hide in the dry portion of the enclosure. Water was
exchanged every 8 d and waste was decontaminated with bleach
before disposal. Frogs were fed with small domestic crickets (Acheta
domesticus), fruit flies (Drosophila hydei), or a mixture of both every
other day. All E. prosoblepon were housed indoors in individual 2 L
plastic enclosures containing water and large leaves. They were fed
with D. hydei every other day.
Experimental Design
Frogs were captured by hand using a fresh pair of gloves for
each capture. Before swabbing the frogs, they were rinsed with
approximately 20 ml filter sterilized water to remove debris and
transient bacteria not associated with the skin [15]. Upon capture,
each C. panamansis was swabbed twice with a sterile rayon swab
(Copan, Brescia, Italy) on the thighs, hands and feet 5 times and 10
times on the ventral surface. Swabs were then immediately stored
at 215uC. The first swab was used for the analysis of the microbial
skin community as described below, and the second swab was
given to Roberto Iba´n˜ez at the Smithsonian Tropical Research
Institute in Panama City, Panama to test for Bd by qPCR
according to Boyle et al. [51]. Rocket frogs were distributed
randomly among three treatment groups. Glass frogs, E.
prosoblepon, were collected on January 11 and 12, and rocket frogs
were collected on January 13–15. After determining Bd infection
status of all individuals, treatments of rocket frogs began January
24 (day 1). A second swab for microbial skin community analysis
was obtained on day 48, at which time skin peptides were also
sampled, marking the end of the experiment and a biologically
relevant time point for assessing changes in skin peptides.
Collection of microbes and skin peptides from E. prosobleopon
occurred as soon as possible after use of frogs in the experiment
(day 14).
Probiotic treatment. Frogs (n = 15) were exposed to the
antifungal bacterium, Lysinibacillus fusiformis. In January 2010, L.
fusiformis was isolated from the skin of a C. panamansis from Tortı´,
Panama and cryopreserved at STRI until use. The isolate was
identified by Matthew Becker at Virginia Tech University and the
16S rDNA sequence has been deposited in the EMBL Nucleotide
Sequence Database (accession number HE817768). The host frog
was not infected with Bd, although some other amphibians at the
site were Bd positive including two Craugastor crassidigitus out of 93
sampled amphibians. Some strains of the bacterium can produce
tetrodotoxin [52] and have the capacity to inhibit Bd growth in the
laboratory. Thus, Dendrobatid frogs may form symbioses with this
bacterium to increase antimicrobial or anti-predator defenses.
Bacteria were incubated for 96 h at room temperature on glucose-
casein-KNO3 agar plates (containing 0.5 g glucose, 0.3 g casein,
2 g KNO3, NaCl and K2HPO4, 0.05 g MgSO4*7H2O, 0.03 g
CaCO3, 0.01 g FeSO4*7H2O and 20 g agar per L medium). After
incubation, L. fusiformis was washed from the agar plate with filter-
sterilized water and 25 ml of the bacterial solution was poured into
each of fifteen 50 ml centrifuge tubes. Rocket frogs were placed
individually into the tubes for 1 hr. This treatment was performed
once, on day 1 of the experiment.
Host Microbiota Resist Probiotic Colonization
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Transplant treatment. Frogs (n = 15) were exposed to skin
washes from E. prosoblepon (n = 16). Glass frogs appear to have an
exaptation to resist Bd and pre-existing mucosal defenses that
protect nests from pathogenic fungi [32]. Glass frogs were given
daily washes in 25 ml of filter-sterilized water for 30 min. All skin
washes were then mixed together and 25 ml applied to each of the
15 C. panamansis for 30 min in 50 ml centrifuge tubes. Starting on
day 1 of the experiment, the treatment was repeated once daily for
7 d.
Control treatment. Frogs (n = 14) were held as controls with
a handling regime matching that of the transplant treatment.
Control frogs were given a daily wash in 25 ml filter sterilized
water for 30 min each of 7 d starting on day 1 of the experiment.
Any affect of stress from handling or daily treatment washes was
matched in these controls.
Data Collection
Frog mass. The mass of all C. panamansis was measured on
day 1, day 28 and day 48 of the experiment. To test for treatment
effects on mass we used repeated measures ANOVA. Slope of
mass change through time was compared among treatment groups
by ANOVA with Tukey HSD pairwise comparisons. All statistical
tests were carried out with IBM SPSS Statistics v. 19 (SPSS Inc.)
unless otherwise indicated, and non-parametric tests were used
when data were not normally distributed and had heterogeneous
variances (Levene’s test, P.0.05).
Microbiota. Dynamics of bacterial communities were inves-
tigated by terminal-restriction fragment length polymorphism (T-
RFLP), a consistent and high-resolution culture-independent
technique used to monitor microbial community changes over
space or time [53–56]. DNA was extracted from swabs with the
Microbial Ultra Clean DNA Kit (MO BIO) following the protocol
of the manufacturer. Bacterial 16S rDNA was then amplified using
the primer 27F (PETH labelled) (59-AGA GTT TGA TCC TGG
CTC AG-39) and 1492R (59-TAC GGY TAC CTT GTT ACG
ACT-39) (Applied Biosystems). For the 20 ml PCR reaction
mixture, the thermocycling conditions were set as follows: 95uC
for 5 min followed by 32 cycles of 94uC for 1 min, 52uC for
1.5 min, 72uC for 2 min and a final elongation for 10 min at
72uC. Each reaction contained the following reagents: 2 ml
template DNA, 1 ml of each primer (10mM), 1 ml BSA (2 ug/ml),
2 ml dNTPs (2 mM), 4 ml buffer (5x), 1.2 ml MgCL2 (25 mM), 1 ml
Taq 1:10 (0.5 u/ml), and 6.8 ml water.
To minimise PCR bias, PCR reactions were run in triplicate
and their products combined and checked by electrophoresis in
1% agarose with GelRED staining. In order to eliminate pseudo-
terminal fragments [60],10 units of mung bean nuclease and 12 ml
of 10x reaction buffer were added to the PCR product to digest
single-stranded DNA. The digestion was performed with a total
volume of 120 ml at 30uC for 2 h. To stop the reaction, SDS
(0.1%) was added to a final concentration of 0.01%. Mung bean
digested PCR products were purified with the GenElute PCR
Clean-Up Kit (Sigma-Aldrich) according to the protocol provided
by the manufacturer until step IV and then eluted with 33 ml of
Elution Solution.
Using a spectrophotometer (NanoDrop), the absorption of
samples at 260 nm was determined to quantify DNA. Samples
were diluted with Milli Q water to a DNA concentration of 50 ng
ml21 and aliquots of the samples (200–500 ng) were digested with
restriction enzymes. For the 20 ml restriction reaction, 1.5 units of
either HaeIII or MspI were used with 2 ml of 10x FastDigest or
10x Tango buffer respectively.
To determine restriction fragment lengths, 2 ml of digested PCR
product were run on an ABI 3730 DNA Analyser (Applied
Biosystems) equipped with 36 cm capillaries filled with POP7
polymer. For each sample, we used 17.8 ml HiDi-Formamide
(Applied Biosystems) and 0.2 ml GeneScan 500 LIZ size standard
(Applied Biosystems). T-RF sizes and quantities, measured in
fluorescence units (rfu), were determined with GeneMapper v3.7
(Applied Biosystems) using the AFLP option and the Local
Southern size calling method. Peak alignment was done automat-
ically by GeneMapper and peak parameters were set to a
polynomial degree of 4, window size of 13 and a minimum of
width at half maximum (base pairs) of 2. To exclude possible
primer dimers or other artifacts, we analyzed peaks in the range of
80–411 bp (HaeIII) and 80–596 bp (MspI) with intensities of
$150 RFU. Samples with less than 2 peaks were removed from
the data set; in total, 6 samples digested with HaeIII and 3 samples
digested with MspI were discarded. By calculating the area of each
peak as a proportion of the total area, data were standardized in
Microsoft Excel and the resultant data set imported into the
statistical software package PAST. T-RFLP data were visualized
by non-metric multidimensional scaling (nMDS) and hypotheses
tested by analysis of similarity (ANOSIM) using Bray-Curtis
coefficient similarity matrix, and by non-parametric multivariate
analysis of variance (NPMANOVA). As a second method of
microbial community analysis, the number of taxa detected in
every sample was counted (assuming that each peak represents one
single species) and the Simpson and Shannon indices for diversity
were calculated in PAST v2.10. These measures of diversity were
used to test for differences among treatment groups by ANOVA or
to test for changes in microbial diversity through time with paired
t-tests.
Skin peptides. On day 14 of the experiment, all E. prosoblepon
were swabbed for microbial community analysis, and afterward,
skin peptides were collected. Frogs were given a dorsal subcuta-
neous injection of 40 nmol norepinephrine (bitartrate salt; Sigma)
per g body weight (gbw) to elicit granular gland secretions, then
rinsed with 25 ml filter sterilized water and allowed to sit for
15 min. Peptide mixtures were acidified to 1% hydrochloric acid
(HCl) to prevent proteolytic degradation of samples. The solution
was immediately passed over C-18 Sep-Pak cartridges (Waters
Corporation) previously primed with acetonitrile and rinsed, and
the Sep-Paks were stored in zip-lock bags with 2 ml of 0.1% HCl.
After transport to the University of Zu¨rich, peptides bound to the
Sep-Paks were eluted with 70% acetonitrile, 29.9% water, and
0.1% HCl and concentrated to dryness by centrifugation under
vacuum, and weighed. The same procedure was used to collect
peptides from C. panamansis after swabbing them at the end of the
experiment for microbial community analysis on day 48.
To test the extracted skin peptides for antimicrobial activity, the
growth inhibition of Bd zoospores was measured for a subset of
samples from each C. panamansis treatment group and from E.
prosoblepon. The dried peptides were dissolved in water and diluted
to a concentration of 1000 mg ml21 before addition to a 96-well
plate in duplicate. The final peptide concentration was 500 mg
ml21 in the wells containing 50 ml peptide and 50 ml Bd zoospores
in 1% tryptone broth (T broth). Preliminary tests showed that
lower concentrations had no significant effects on the growth of
zoospores (data not shown). To obtain Bd, an RIIA agar plate
supplemented with 1% tryptone was inoculated with the panzootic
lineage of Bd from the UK (generously provided by M. Fisher),
grown for 7 d, and flushed with 3 ml of T broth. After a 15 min
incubation, the T broth with freshly released and active zoospores
at 4.26106 zoospores ml21 was collected in a sterile reagent
reservoir. The 96-well plates were prepared: 100 ml of T broth was
added to all outer wells to retain moisture in the plate. Control
wells in replicates of 6 contained 50 ml water and 50 ml of Bd
Host Microbiota Resist Probiotic Colonization
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zoospores heat killed for 15 min at 60uC (negative control) or
50 ml of living Bd zoospores (positive growth control). The optical
density at 490 nm was measured on days 0 and 7 on a multilabel
counter (Victor3, Perkin Elmer) and plates were incubated at
18uC, an optimal temperature for Bd growth [57]. The percentage
of Bd growth inhibition for each peptide sample was calculated by
comparison to controls. The percentage of Bd growth inhibition
was then multiplied by the quantity of peptides produced per cm2
surface area to calculate the peptide capacity against Bd. Peptide
capacity is similar to the measure of peptide effectiveness used by
Woodhams et al. [58] for small frogs where large quantities of
peptides are not available for testing minimal inhibitory concen-
trations. The skin surface was estimated using the equation:
surface area = 9.90*(weight in grams)0.56 [59]. We tested for
differences among treatments and species in the quantity of
peptides recovered, growth inhibition of Bd (%), and peptide
capacity by ANOVA with Tukey HSD pairwise comparisons.
To test for differences in the composition of skin peptides
among the three C. panamansis treatment groups, skin peptides
were analyzed. Ultra-high performance liquid chromatography
electrospray ionization mass spectrometry (UHPLC-ESI-MS) was
performed on a Waters Acquity UPLC (Waters, Milford, MA
01757, USA) connected to a Bruker maxis high-resolution
quadrupole time-of-flight mass spectrometer (Bruker Daltonics,
Bremen, Germany). An Acquity BEH 300 C18 column (Waters,
1.7 mm, 16100 mm) has been used with a gradient of
H2O+0.05% TFA (A) and CH3CN+0.05% TFA (B) at 0.2 mL/
min flow rate (linear gradient from 10 to 50% B within 10 min
followed by flushing with 100% B for 4 min). All solvents were
purchased in best LC-MS qualities.
The mass spectrometer was operated in the positive electrospray
ionization mode at 49500 V capillary voltage, –500 V endplate
offset, with a N2 nebulizer pressure of 1.4 bar and dry gas flow of
10.0 L/min at 200uC. MS acquisitions were performed in the
mass range from m/z 100 to 39000 at 209000 resolution (full width
half maximum) and 2 scans per second. The MS instrument was
optimized for maximum intensities of Bradykinin at m/z 530.8.
Masses were calibrated with an electrospray calibrant solution
(Fluka, Buchs, Switzerland, 20x dilution in CH3CN) between m/z
118 and 2722.
The relative abundance (area under peak) of 16 peptides was
determined by HPLC-MS for a subset of samples from each
treatment group and species. The relative intensities of each
peptide were ranked to produce a dataset that satisfied Box’s test
for homogeneity of covariance matrices. Differences in peptide
profiles among treatments were analyzed by multivariate analysis
of variance in PAST v2.16. Peptide dry weight was compared with
the ranked intensity of the ubiquitous peptide (mass 1064) by
linear regression to determine whether dry mass measurements of
partially purified skin secretions enriched for hydrophobic peptides
could predict the relative abundance of peptide peaks detected by
HPLC. To test for a potential immune-energetic trade-off, the
quantity of peptides recovered was tested for correlation with
change in frog mass. Peptide composition was also tested for affect
on frog mass by multiple linear regressions, overall and separately
for each treatment.
Results
Survival, Bd Infection, and Body Mass
The survival rates of C. panamansis (N = 44) in the three different
treatments were as follows: 86.7% for the probiotic treament,
85.7% for the control treatment, and 78.6% for the skin wash
transplant treatment. Five frogs, randomly divided among
treatments, were found to be infected with Bd but none of these
frogs died during the experimental period. Mass loss of infected
frogs was not significantly different than mass loss of uninfected
frogs (Independent t-test, t37 =20.075, P = 0.940). At the start of
the experiment, mass of frogs did not differ significantly among
treatments (mean +/2 SD = 1.52+/20.28 g, ANOVA,
F2,36 = 0.667, P = 0.519). Treatment groups differed significantly
in the change of body mass through time (Repeated measures
ANOVA, Greenhouse-Geisser F3.3,56.6 = 3.168, P = 0.027). Mass
loss was greatest in frogs treated with L. fusiformis (slope of mass
loss, ANOVA, F2,36 = 3.850, P = 0.031; Fig. 1a). Mass loss was on
average 11.9% for probiotic treated frogs, 0.1% for control frogs,
and 7.3% for skin-wash transplant treated frogs.
Microbiota Composition
We did not detect significant differences in the composition of
microbiota among the three different groups either before or after
treatment (Table 1). The microbiota of all treatment groups
changed over time (nMDS, Fig. 2; ANOSIM and NPMANOVA,
Table 1), but the stress values of the nMDS plots were high and R
values of the ANOSIM low, indicating that the changes were very
small. Hence, the microbiota did not differ significantly among
treatments at the beginning of the experiment, microbiota shifted
to a small degree through time in the mesocosms, and microbiota
did not significantly differ among treatments at the end of the
experiment. The microbiota found on E. prosoblepon was signifi-
cantly different to that found on C. panamansis (treatment groups
combined) at all times (NPMANOVA, before: F = 4.814,
P = 0.0001; after: F = 3.529, P = 0.0001).
For terminal restriction fragments (TRFs) hydrolysed with
HaeIII, the number of detected taxa varied between 3 and 20
before and 2 and 14 after treatment. For MspI between 2 and 18
taxa were found both before and after treatment. There was no
change in the Shannon index of diversity, and similarly the
Simpson index, detected for either enzyme over time (paired t-test
for combined treatments; HaeIII: t =21.307, P = 0.200; MspI:
t = 1.431, P = 0. 1617) nor among treatment groups.
Using pure culture standards and T-RFs obtained from
cleavages of the 16S rDNA by several enzymes, T-RFLP can be
used identify species within microbial community profiles [55].
The bacterium L. fusiformis was initially detected on one frog that
died during the experiment (fragment lengths: 148 for Msp1 and
235 for HaeIII) and was not found on any frogs at the end of the
experiment including those treated with live cultures of L.
fusiformis.
Skin Peptides
The quantity of peptides measured at the end of the experiment
differed significantly among the C. panamansis treatment groups
(Kruskal-Wallis test, P = 0.025). Frogs treated by skin wash
produced significantly less peptide per surface area than frogs
treated with L. fusiformis (Mann-Whitney U test, P = 0.015), and
control frogs were intermediate. Peptide recovery was highest in
frogs treated with the probiotic, and frogs in this group also lost the
most body mass during the experiment; however, there was not a
significant overall correlation between peptide production and
change in mass (Pearson correlation, r =20.175, P = 0.308). Nor
was there a significant affect of peptide profile on slope of mass
when analyzed by multiple linear regressions overall or separately
for each treatment (P’s .0.05).
Bd growth inhibition caused by 500 mg ml21 peptides also
differed significantly among C. panamansis treatments (ANOVA,
F3,23 = 34.492, P,0.0001) and was greatest in frogs treated with
skin washes from E. prosoblepon. The capacity of peptide defenses
Host Microbiota Resist Probiotic Colonization
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against Bd differed significantly among treatment groups and
species (Fig. 1b). Frogs treated with L. fusiformis had at least twice
the peptide capacity to inhibit Bd than frogs in any other group
(Fig. 1b).
Rocket frogs, C. panamansis, expressed between 1 and 16 skin
peptides (mean = 4.8) detected by HPLC (Table 2, Fig. 3).
Common skin peptides included molecular weight 1005.6,
1064.0, and 3306.6. Glass frogs, E. prosoblepon, produced a
different set of skin defense peptides (Table 2, Fig. 3). Primary
structures have not been described. Skin peptide profiles were not
significantly different among treatments of C. panamansis (MAN-
OVA, Wilks’ Lambda, F18,50 = 0.756, P = 0.738). Similar results
were obtained with non-parametric tests of untransformed data.
Overlapping peptide profiles suggest that peptide quantity, rather
than profile, was primarily affected by treatment, with the
exception of one peptide.
Peptide of mass 1064 was present in all C. panamansis samples,
and was the only peptide that differed in relative abundance
among treatment groups (ANOVA, F2,33 = 3.611, P = 0.038). This
peptide was most abundant in transplant treated frogs, least
abundant in probiotic treated frogs, and intermediate in controls.
There was a significant correlation between total peptide dry mass
and rank intensity of peptide mass 1064 (Fig. 4; overall Pearson
correlation, r = 0.672, N = 36, P,0.001, R2 = 0.4522). Treatment
accounted for 26.4% of the total variance in rank peptide intensity
controlling for the effect of peptide quantity (ANCOVA,
Figure 1. Body mass change and capacity of skin defense peptides against Batrachochytrium dendrobatidis (Bd) of frogs in different
treatments. (a) Slope of mass change. (b) Peptide capacity calculated as peptide quantity per surface area multiplied by percent growth inhibition
of Bd caused by 500 mg ml21 peptide for each treatment or species. Letters above bars indicate homogeneous subsets based on ANOVA with Tukey
HSD.
doi:10.1371/journal.pone.0087101.g001
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F2,32 = 17.124, P,0.001, v
2 = 0.264). Thus, higher total peptide
quantity was associated with lower relative abundance of peptide
mass 1064 in a treatment-specific pattern (Fig. 4).
Discussion
Stability of Skin Microbiota
Probiotic therapy is a promising disease mitigation strategy
currently under development as many amphibian populations
Table 1. Statistical analysis of treatment differences in microbial communities described by T-RFLP using either Hae3 or Msp1
enzymes.
ANOSIM NPMANOVA
Msp1 Hae3 Msp1 Hae3
R p R p F p F p
before treatment
P vs. C 20.0980 0.9910 20.0660 0.9170 0.2900 0.9980 0.5100 0.9720
P vs. T 20.0360 0.7450 20.0470 0.8270 0.5700 0.8960 0.6000 0.8750
C vs. T 20.0560 0.9240 20.0220 0.6420 0.6200 0.8820 0.7900 0.6920
after treatment
P vs. C 20.0300 0.7490 0.0350 0.1930 0.9600 0.4900 1.2700 0.2040
P vs. T 0.0000 0.4230 20.0230 0.6220 0.9900 0.4350 0.7800 0.6370
C vs. T 0.0080 0.3600 0.0030 0.3880 1.2200 0.2230 1.0900 0.3240
before, after
Treaments combined 0.1860 0.0001 0.1420 0.0001 5.6830 0.0001 3.9450 0.0001
Analysis of similarity (ANOSIM) and non-parametric multivariate analysis of variance (NPMANOVA) results are shown of the three C. panamansis treatments: P = probiotic
treatment, C = control treatment, T = transplant treatment. Significant values identified by ANOSIM and NPMANOVA are indicated in bold.
doi:10.1371/journal.pone.0087101.t001
Figure 2. Skin microbial communities of Colostethus panamansis. Communities before (circles, field samples) and after (crosses, day 48)
treatments visualized by non-metric multidimensional scaling (nMDS) of T-RFLP analysis using enzymes HaeIII and MspI. Treatments are numbered to
indicate probiotic bacterium Lysinibacillus fusiformis (1,2), control (3,4), and skin-wash transplant from the disease-resistant glass frog Espadarana
prosoblepon (5,6). Microbial communities were not significantly different among treatments within each time-point represented by convex hulls.
Distance between objects on the plot represents relative dissimilarity (axes are in arbitrary units). Stress ,0.1 indicates strong community differences
and stress .0.2 indicates that differences should be interpreted with caution. Statistical analyses are presented in Table 1.
doi:10.1371/journal.pone.0087101.g002
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decline worldwide [13,24,33]. Applications of probiotics may be
considered a managed pulse disturbance of the microbial
community, but the response to disturbance in terms of stability
of host-associated microbiota has not previously been tested. We
found that an amphibian species threatened by chytridiomycosis in
Panama had a remarkably stable skin microbiota that was resistant
to alteration by experimental treatments with skin washes from a
co-occurring disease-resistant species, and with the potential
probiotic bacterium L. fusiformis. Although L. fusiformis is a naturally
occurring symbiont of C. panamansis, and may be responsible for
defensive tetrodotoxin compounds found in the skin of Dendro-
batids [52,61], the bacterium did not establish. We did not detect
tetrodotoxin production from the bacterium grown in isolation (K.
Minbiole, unpublished data). Mechanisms maintaining bacterial
communities on amphibian skin have not been previously
described. Skin defense peptides extracted from the skin of C.
panamansis inhibited the growth of the pathogenic fungus
Batrachochytrium dendrobatidis and contributed to host mechanisms
maintaining the microbial composition of C. panamansis by limiting
L. fusiformis and exogenous microbes from E. prosoblepon skin
washes. Application of L. fusiformis led to increased peptide
capacity against Bd in C. panamansis.
Although the probiotic bacterium originally isolated from C.
panamansis did not establish under our experimental conditions, the
composition of the skin microbiota of C. panamansis changed over
the course of the 48 d experiment in all treatments. Thus, the skin-
associated microbial community was resistant to experimental
disturbance but showed a gradual shift through time, and was
perhaps more influenced by environmental conditions than
exogenous microbial exposure. The temperature in the mesocosms
at El Valle over the course of the experiment (mean 22.8uC) was
probably a little lower than that of the lowland rainforest at Sierra
Llorona lodge were the frogs were captured. This factor could also
have initiated a shift in the microbial communities on the frog skin.
The degree to which amphibians depend on their environment or
contact with conspecifics to maintain their microbiota long-term is
unknown, but other studies have shown slight changes in microbial
diversity through time in captivity [36,62]. Here, regulation of
microbiota by host immune factors [63] is supported.
How amphibians acquire the microbiota on their skin remains
unclear. Plausible routes of transmission include contact with
conspecifics (horizontal transmission), habitat (environmental
transmission), or parents (vertical transmission [32]). Colonization
of L. fusiformis on the skin of adult C. panamansis after contact with
high concentrations of bacteria was not successful, and there are
several potential explanations. (1) Colonization may begin at early
developmental stages when the microbiota reaches a stable
equilibrium that then resists disturbance [64,65]. (2) Competition
for resources such as nutrients or space could have prevented
establishment of a new member of the skin microbiota [66,67]. (3)
Resident microbiota may have prevented the invasion of L.
fusiformis by the production of antibiotic metabolites or bacteriocins
[68,69]. (4) Host immune factors in the skin including AMPs [37]
may have been induced and excluded L. fusiformis.
Antimicrobial defense peptides extracted from the skin of C.
panamansis differed significantly among treatments in quantity and
in relative abundance of peptide mass 1064. This peptide will be
targeted in future studies for primary structure determination and
for testing of antifungal function. C. panamansis exposed to
potentially beneficial bacteria and other host factors in the mucus
washed from the skin of E. prosoblepon did not increase overall
peptide quantity, but did show an increase in the relative
abundance of peptide mass 1064 and a corresponding increase
in Bd inhibition at a standardized concentration of 500 mg ml21
peptide. C. panamansis exposed to cultured L. fusiformis produced
greater quantities of AMPs than frogs in the other two treatment
groups, leading to greater defense capacity against Bd (Fig. 1), and
suggesting a generalized induced immune response. Similarly,
Schadich et al. [70] described increased peptide production in the
frog Litoria raniformis induced by exposure to the pathogenic
bacterium Klebsiella pneumoniae. In this study, induction of skin
defense peptides likely contributed to the elimination of L.
fusiformis, and the inability of the probiotic to establish within the
host skin microbial community. At the same time, frogs in the L.
fusiformis treatment lost significantly more weight than frogs in
other treatments, indicating a potential cost to immune activation
[71]. Certainly, other host responses in addition to skin peptides
may have occurred simultaneously, contributing to the observed
treatment effect on mass loss.
Susceptibility to Chytridiomycosis
Soon after the arrival of Bd at Omar Torrijos National Park in
2004, C. panamansis populations declined critically [27,29], whereas
the frogs sampled near the Sierra Llorona lodge appeared to be
Table 2. Retention time (Rt), molecular weight (MW),
prevalence, and mean relative area of each peptide based on
HPLC-MS chromatograms.
Rt (min) MW Prevalence (%) Mean relative area
Colostethus panamansis (N = 36)
3.6 1041.5 61 0.14
4.45 1064.0 100 1.00
4.5 3306.6 72 0.35
4.8 1936.2 25 0.12
5.0 1512.0 42 0.28
5.3 2988.6 3 0.03
5.3 3001.5 3 0.02
5.7 2986.6 6 0.20
7.0 2974.5 17 0.65
6.8 2957.7 17 0.57
7.1 2972.6 17 0.93
7.0 2290.4 11 1.07
7.3 2231.4 6 0.63
7.6 2315.4 6 0.94
8.1 1005.6 94 1.66
9.7 1790.0 6 0.13
Espadarana prosoblepon (N = 16)
1.45 1746.7 81 0.02
2.2 1585.8 94 0.31
3.7 2650.2 100 0.72
4.4 2698.2 100 1.14
4.55 2634.2 100 0.74
4.6 2652.2 100 0.37
4.75 1004.6 100 0.39
5.05 1004.6 100 0.51
5.45 2681.2 100 1.00
5.69 2665.1 38 0.06
Area is relative to a consistently observed peak, MW 1064.0 for C. panamansis
and MW 2681.2 for E. prosoblepon.
doi:10.1371/journal.pone.0087101.t002
Host Microbiota Resist Probiotic Colonization
PLOS ONE | www.plosone.org 7 January 2014 | Volume 9 | Issue 1 | e87101
coexisting with Bd, with a prevalence of 11.4% (95% binomial
confidence interval: 3.8–24.6%). That C. panamansis are able to
persist in an area with Bd may be due to infection tolerance [72] or
related to habitat characteristics. Temperatures in the lowland
rainforest near Sierra Llorona lodge are typically higher than in
the cloud forest habitat at Omar Torrijos National Park.
Environmental factors such as temperature can also influence
the synthesis and expression of skin defense peptides in amphibians
[37,73]. While none of the frogs in this study showed clinical signs
of chytridiomycosis, infection status may be an important driver of
immune function, or a response to immune function including
AMPs and microbiota, and thus an important target for future
investigation. In particular, does microbial therapy have the same
effect as a treatment of infection as it does as a prophylactic
treatment?
Based on samples taken before Bd emergence at Omar Torrijos
National Park [58], E. prosoblepon skin defense peptides were
expected to be more effective against Bd growth than C. panamansis
peptides. Thus, similar or greater Bd growth inhibition caused by
skin peptides from all three treatment-groups of C. panamansis
compared to E. prosoblepon peptides in this study was unexpected.
In contrast to C. panamansis, E. prosoblepon has been able to survive
for more than 8 yr at Omar Torrijos National Park, and 16 yr at
Fortuna in the presence of Bd [27,30]. We found higher values of
peptide effectiveness against Bd than previously reported for C.
panamansis, and this might be explained by population origin of the
frogs. Glass frogs, E. prosoblepon, were sampled from the same
upland site as in the previous study, while C. panamansis were
Figure 3. Representative chromatograms of skin defense peptides examined by HPLC-MS. (a) Colostethus panamansis. (b) Espadarana
prosoblepon. Values of molecular weight and mean area for the detected peptides are reported in Table 2.
doi:10.1371/journal.pone.0087101.g003
Figure 4. Peptide dry mass predicts a significant proportion of
variation in peptide intensity determined by LC-MS. Overall,
there was a significant correlation between peptide dry mass and rank
abundance of peptide mass 1064. This relationship differed among
treatments indicating a change in the relative abundance of the
peptide components of skin secretions depending on microbial
treatment. Transplant treated frogs had the highest relative abundance
of peptide mass 1064 (lowest rank), and probiotic treated frogs the
lowest relative abundance with controls intermediate. Probiotic treated
frogs had significantly higher total quantity of peptides than transplant
treated frogs (see text).
doi:10.1371/journal.pone.0087101.g004
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extirpated from the upland site and for this study frogs were
captured from a lowland rainforest habitat. AMPs from these frogs
may have been up-regulated by exposure to Bd or microbiota, or
AMP defenses may differ among populations or habitats [74].
Stressors may also differ among sites, and long-term upregulation
of stress hormones including glucocorticoids can suppress immu-
nity [75] including AMP skin defenses in amphibians [76]. Besides
the invasion of Bd at Omar Torrijos National Park, stressors have
not been reported [29].
Considerations for Probiotic Therapy
Promoting and sustaining human health through strategies that
manipulate microbial communities is a long-term goal of the
Human Microbiome Project [77]. Thus, amphibians and other
model vertebrate systems are important for examining host-
microbiota interactions to gain a mechanistic understanding of
microbial community assembly and maintenance [62]. Probiotic
disease mitigation is also high on the list of conservation options
available for threatened amphibians [13,24].
An intuitive strategy of reducing the biomass or diversity of
resident skin microbiota may aid in the establishment of new
bacteria by minimizing community interactions. However, antibi-
otic pre-treatment interfered with intestinal microbial community
establishment in rats [78]. Becker et al. [35] first washed golden
frogs, Atelopus zeteki, in a 1.5% solution of hydrogen peroxide to
reduce microbiota before probiotic treatment. However, the
bacterium Janthinobacterium lividum did not establish on the skin of
the frogs. Pathogens can become established in hosts treated with
antibiotics by exploiting the reduced competitiveness of the
disturbed community [79], and intestinal disease has been linked
to the outgrowth or loss of certain components of the microbiota
[80–82]. Conversely, beneficial bacteria can also establish in hosts
and many examples of successful probiotic use have been reported
in aquaculture [83], livestock and poultry production [84], as well
as in human medicine [85,86].
A recommended step for probiotic application is to use small
probiotic doses and to wash bacterial cultures in a physiological
solution to ensure that hosts are exposed to the living cells only,
minimizing exposure to metabolic products of the bacteria
including immunomodulatory toxins [34,35]. Metabolites from
unwashed whole cultures may help bacteria in microbial
competitive interactions; however, toxins or inordinately large
probiotic doses may also elicit host immune responses. It remains
unclear whether pre-treatment steps to reduce endogenous
microbiota or to wash beneficial bacteria are necessary to
introduce an exogenous bacterium into an existing microbial
community, but this is a critical consideration for use of probiotics
in disease management. The bacterium J. lividum, used by Harris
et al. [34] on Rana muscosa was likely already present on many of
the frogs and represents a bio-augmentation experiment. Thus,
altering relative population sizes and community function within
an established microbiome may be more feasible than altering
community membership.
The composition of microbiota can affect host immune
responses and influence disease outcome. For individuals with
functional skin microbiota and immune defense, colonization
resistance can be beneficial, for example in times of environmental
change. On the other hand, a resistant or resilient microbiota is
not desirable for enhancing host disease resistance through
probiotic therapy. Probiotic therapies aim to alter the microbial
community to a new stable state that is more protective than the
previous state [7]. Establishment of novel microbiota may require
methods to circumvent host mechanisms maintaining the micro-
biota. In the case of C. panamansis from Panamanian lowlands, the
combination of microbiota that are resistant to colonization, and
AMPs effective at inhibiting Bd growth, may favor infection
tolerance and population persistence. The continuing develop-
ment of probiotic strategies offers hope for populations threatened
by infectious disease.
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